Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

2.05
-0.2100-9.29%
Post-market: 2.050.00000.00%16:19 EDT
Volume:920.11K
Turnover:1.96M
Market Cap:56.90M
PE:-2.96
High:2.24
Open:2.22
Low:1.97
Close:2.26
52wk High:2.60
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:2.92
T/O Rate:3.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:2.79
PE(LYR):-1.10

Loading ...

INmune Bio Adds Sanofi Rare-Disease Executive Duane Clark, Dealmaker James Sapirstein to Board

Reuters
·
Sep 14

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

THOMSON REUTERS
·
Sep 14

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire
·
Sep 09

INmune Bio Submits EMA Orphan Drug Application for Ebstrocel in RDEB

Reuters
·
Aug 26

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with Ema Regulatory Filings

THOMSON REUTERS
·
Aug 26

INmune Bio - Company Targets UK Maa in Q4 2026, EU Maa and U.S. Bla in Q1 2027

THOMSON REUTERS
·
Aug 26

INmune Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

INmune Bio Q2 Net Loss Narrows on Lower Impairment Charges

Reuters
·
Aug 07

INmune Bio Q2 EPS $(0.05) Beats $(0.21) Estimate

Benzinga Earnings
·
Aug 07

INmune Bio Q2 Basic EPS USD -0.05

THOMSON REUTERS
·
Aug 07

INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

THOMSON REUTERS
·
Aug 07

INmune Bio Inc Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 05

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

THOMSON REUTERS
·
Jul 31

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6TH

THOMSON REUTERS
·
Jul 31

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

GlobeNewswire
·
Jul 31

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

GlobeNewswire
·
Jul 30

INmune Bio Meets Milestone for CORDStrom Platform; Plans to Apply for BLA With US FDA

MT Newswires Live
·
Jul 20

Inmune Bio Reports Press Release Available

Reuters
·
Jul 20

Inmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for Cordstrom™ Platform

THOMSON REUTERS
·
Jul 20

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform

GlobeNewswire
·
Jul 20